Company Overview and News

26
Intel, AMD And Nvidia Are No Longer A Zero-Sum Game

1h seekingalpha - 1
AMD’s gain in CPU market share is often considered Intel’s loss. AMD’s gain in the GPU market share is Nvidia’s loss. This is referred as a zero-sum game.
XLNX AMD NVDA INTC

6
IBM: How About A CEO Change?

3h seekingalpha
One of Wednesday's biggest losers so far is IBM (IBM), after the company reported third quarter results Tuesday afternoon. While the report showed another adjusted bottom line beat, it was the top line that surprised in a big way, and not to the good side. As the revenue picture continues to be quite murky, perhaps it is time for a change in leadership.
AAPL DIA CSCO MSFT INTC CSCOI

38
The Key Question Facing Nvidia Stock

3h investorplace - 1
It’s important not to overreact to the recent declines in Nvidia (NASDAQ:NVDA) stock. Long-term, I still believe Nvidia stock is a buy. Short-term, it has been a different story. Nvidia stock has fallen 18% in just the last eight trading sessions before today.
LRCX SOXX SQ SHOP TXN MU AMAT AMD NVDA QCOM INTC

7
SoftBank 'anxiously' monitoring Saudi Arabia situation: executive

3h channelnewsasia
Softbank Group Chief Operating Officer Marcelo Claure said it is "business at usual" at the companies backed by its nearly US$100 billion Vision Fund despite a tense situation with Saudi Arabia, which provided nearly half of the fund's capital.
AAPL 9984 SFTBF INTC QCOM SFTBY

43
7 Titans of the Dow Jones With More Upside to Come

2018-10-16 investorplace
Last week, just days after flirting with the 27,000 threshold and setting new record highs, the Dow Jones Industrial Average plunged on worries over the impact rising long-term interest rates would have on the economy amid the Federal Reserve’s ongoing tightening cycle. This week, after the harrowing selloff, U.S. equities found respite thanks to these Dow Jones stocks.
DB CVX VZ KO BA INTC MCD DIS

62
Jerry Maguire Stock Market

2018-10-16 seekingalpha
A big trend developed in 2016-2018 and the stock market went all-in on revenue growth stories, especially in technology stocks.
FB AMZN GOOGL AAPL CSCO KO MSFT NFLX GOOG INTC DIS

28
Should You Buy Micron Stock on the Dip?

2018-10-15 investorplace
Micron Technology (NASDAQ:MU), which provides semiconductor systems, has had a difficult time since June. So far in October, it has suffered further along with other technology stocks. While high volatility in the broader technology market is likely to continue for several more weeks, there are two mildly bearish plays in MU stock that I want to share with you, as each play could lead to impressive profits.
MU AMD NVDA INTC

56
7 Stocks to Buy and Hold Through Any Market Selloff

2018-10-15 investorplace - 1
Last week’s market collapse made headlines throughout the world. Even my professional associates who aren’t necessarily investment-savvy asked for my thoughts and guidance. After years of robust returns, the thought of a widespread correction is jarring. Nevertheless, you still want to keep your wits about you, as this is an ideal time to consider which stocks to buy.
AMZN ABX T PX JNJ XOM VZ INTC VZA ABX

2
Intel (INTC) Dips More Than Broader Markets: What You Should Know

2018-10-15 zacks
Intel (INTC - Free Report) closed the most recent trading day at $44.53, moving -0.78% from the previous trading session. This change lagged the S&P 500's 0.59% loss on the day. At the same time, the Dow lost 0.35%, and the tech-heavy Nasdaq lost 0.88%.
LMT VBTX WSFS INTC WSFSL

24
What Is Market Share Worth?

2018-10-15 seekingalpha - 1
Advanced Micro Devices and Intel Corporation have had their share of wins and losses over the years.
AMD INTC

24
AMD Short Interest Drops Again

2018-10-15 seekingalpha - 1
Despite the recent correction from its highs, mostly thanks to the market in a panic over rising interest rates, chipmaker Advanced Micro Devices (AMD) is still one of the year's biggest winners. As the company's turnaround has continued and it looks to steal share from giant Intel (INTC) in the server space, investors have sent AMD shares to multi-year highs. Recently, we've seen short sellers flee their positions in a meaningful way.
AMD INTC

27
NVIDIA Soars in AI Market With New Platform & Partnerships

2018-10-15 zacks - 1
NVIDIA Corporation’s (NVDA - Free Report) efforts in artificial intelligence (AI) and machine learning in various fields are gathering momentum, thanks to its initiatives and adoption of its technologies by key companies. The past week has been quite eventful for NVIDIA. Swedish automaker Volvo Cars chose NVIDIA’s DRIVE AGX Xavier platform, an advanced car computer, to be incorporated in its next-generation automated cars.
AMD NVDA INTC ORCL

6
Samsung, SK chip operations make up 40.2 pct of all profits by top companies

2018-10-14 english.yonhapnews.co.kr
SEOUL, Oct. 14 (Yonhap) -- The semiconductor business of Samsung Electronics Co. and SK hynix Inc. made up 40.2 percent of all operating profit generated by South Korea's top 100 companies this year, industry data showed Sunday.
BC94 SMSN INTC QCOM SMSD

9
The Disconnect Between Memory Chip Output And Processing Equipment Sales: Part 1 Memory Chips

2018-10-13 seekingalpha - 3
Projections of short-term oversupply of DRAM and NAND memory chips are impacting memory companies like Samsung Electronics, Micron Technology, and SK Hynix.
LRCX SSNLF HXSCF MU AMAT AAPL BC94 SMSN INTC HXSCL SMSD

7
Micron to Invest $100M in AI Companies, $1M in AI Research

2018-10-13 zacks
Micron Technology (MU - Free Report) , recently announced that it will spend $100 million in various artificial intelligence (AI) companies, especially hardware and software startups working on AI. Micron Foundation, the non-profit arm of Micron Technology, also announced that it will support universities and non-profit organizations in their research on AI) with a grant of $1 million. These investments by Micron follow investments of similar magnitude which have been made by magnates like Intel (INTC - Free Report) and NVIDIA Corp.
MU VSH NVDA INTC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to INTC / Intel Corp. on message board site Silicon Investor.

AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA Intel Corporation (INTC) Intel Corporation (INTC) Intel Corporation (INTC)
Intel Corporation GOOD to BUY? Intel Corporation GOOD to BUY? Intel Corporation GOOD to BUY? Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC)
AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated Intel STINKS!! BASHERS ONLY!! (Bears Board) Intel STINKS!! BASHERS ONLY!! (Bears Board) Intel STINKS!! BASHERS ONLY!! (Bears Board)
INTC: Intel Corporation INTC: Intel Corporation INTC: Intel Corporation AMD versus INTC arguments AMD versus INTC arguments AMD versus INTC arguments
Earnings: Semiconductor Earnings: Semiconductor Earnings: Semiconductor Intel Strategy for Achieving Wealth and Off Topic Intel Strategy for Achieving Wealth and Off Topic Intel Strategy for Achieving Wealth and Off Topic
CUSIP: 458140100